BR112022017573A2 - Composição compreendendo uma avenantramida ou um análogo da mesma com estabilidade melhorada - Google Patents
Composição compreendendo uma avenantramida ou um análogo da mesma com estabilidade melhoradaInfo
- Publication number
- BR112022017573A2 BR112022017573A2 BR112022017573A BR112022017573A BR112022017573A2 BR 112022017573 A2 BR112022017573 A2 BR 112022017573A2 BR 112022017573 A BR112022017573 A BR 112022017573A BR 112022017573 A BR112022017573 A BR 112022017573A BR 112022017573 A2 BR112022017573 A2 BR 112022017573A2
- Authority
- BR
- Brazil
- Prior art keywords
- composition
- improved stability
- avenantramide
- analog
- avenanthramide
- Prior art date
Links
- IDUUXROOZBOOPH-QHHAFSJGSA-N 2-{[(2E)-3-(3,4-dihydroxyphenyl)-1-hydroxyprop-2-en-1-ylidene]amino}-5-hydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1NC(=O)\C=C\C1=CC=C(O)C(O)=C1 IDUUXROOZBOOPH-QHHAFSJGSA-N 0.000 abstract 3
- 229930190481 Avenanthramide Natural products 0.000 abstract 3
- 239000002537 cosmetic Substances 0.000 abstract 3
- 238000002360 preparation method Methods 0.000 abstract 3
- 235000015872 dietary supplement Nutrition 0.000 abstract 2
- 235000013305 food Nutrition 0.000 abstract 2
- 239000006076 specific stabilizer Substances 0.000 abstract 1
- 230000000087 stabilizing effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/445—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof aromatic, i.e. the carboxylic acid directly linked to the aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/51—Chelating agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Birds (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
COMPOSIÇÃO COMPREENDENDO UMA AVENANTRAMIDA OU UM ANÁLOGO DA MESMA COM ESTABILIDADE MELHORADA. A presente invenção fornece uma composição compreendendo ou consistindo em pelo menos uma avenantramida ou um análogo da mesma ou um extrato de aveia compreendendo uma avenantramida ou um análogo da mesma com uma estabilidade melhorada; seu uso cosmético ou médico; o uso de tal composição para a preparação de alimentos, suplementos alimentares, preparações cosméticas, farmacêuticas ou veterinárias; e alimentos, suplementos alimentares, preparações cosméticas, farmacêuticas ou veterinárias compreendendo uma composição como esta. Finalmente, a presente invenção se refere a estabilizadores específicos para a estabilização de avenantramida(s).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2020/056122 WO2021175453A1 (en) | 2020-03-06 | 2020-03-06 | Composition comprising an aventhramide or an analogue thereof with improved stability |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112022017573A2 true BR112022017573A2 (pt) | 2022-10-18 |
Family
ID=69780214
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112022017573A BR112022017573A2 (pt) | 2020-03-06 | 2020-03-06 | Composição compreendendo uma avenantramida ou um análogo da mesma com estabilidade melhorada |
Country Status (9)
Country | Link |
---|---|
US (1) | US20230131993A1 (pt) |
EP (1) | EP4114348A1 (pt) |
JP (1) | JP2023516453A (pt) |
KR (1) | KR20220151190A (pt) |
CN (1) | CN115209864A (pt) |
BR (1) | BR112022017573A2 (pt) |
CA (1) | CA3172770A1 (pt) |
MX (1) | MX2022010964A (pt) |
WO (1) | WO2021175453A1 (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112022017607A2 (pt) * | 2020-03-06 | 2022-10-18 | Symrise Ag | Composição compreendendo uma avenantramida ou um análogo da mesma com melhorada solubilidade |
WO2023245462A1 (en) * | 2022-06-21 | 2023-12-28 | L'oreal | Stabilized composition comprising thiopyridinone compound |
WO2024042474A1 (en) * | 2022-08-23 | 2024-02-29 | Johnson & Johnson Consumer Inc. | Compositions suitable for use on skin afflicted with eczema |
WO2024042476A1 (en) * | 2022-08-23 | 2024-02-29 | Johnson & Johnson Consumer Inc. | Methods of providing a cooling sensation to skin afflicted with eczema |
WO2024042475A1 (en) * | 2022-08-23 | 2024-02-29 | Johnson & Johnson Consumer Inc. | Methods of improving the appearance of skin afflicted with eczema |
CN115317386A (zh) * | 2022-09-21 | 2022-11-11 | 江西沁华蔓医药科技有限公司 | 提拉紧致抗衰老精华液及其制备方法 |
FR3143357A1 (fr) * | 2022-12-19 | 2024-06-21 | L'oreal | Composition cosmétique aqueuse avec acide ascorbique et arginine |
WO2024150169A1 (en) * | 2023-01-11 | 2024-07-18 | Johnson & Johnson Consumer Inc. | Compositions comprising a retinoid and a processed oat ingredient |
CN117717492B (zh) * | 2023-12-19 | 2024-08-20 | 中山自然说生物科技有限公司 | 一种修复腋窝微生态的生物制剂及其制备方法和应用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6019754A (ja) | 1983-07-14 | 1985-01-31 | Kissei Pharmaceut Co Ltd | 芳香族カルボン酸アミド誘導体の製造方法 |
US4673684A (en) | 1984-04-04 | 1987-06-16 | Terumo Corporation | Amide derivatives and 5-lipoxygenase inhibitors containing the same as an active ingredient |
HU200996B (en) | 1988-05-23 | 1990-09-28 | Biogal Gyogyszergyar | Process for producing n-(3', 4'-dimethoxycinnamoyl)-anthranilic acid (tranilast) |
US6127392A (en) | 1997-08-05 | 2000-10-03 | American Home Products Corporation | Anthranilic acid analogs |
US6096770A (en) | 1998-08-03 | 2000-08-01 | American Home Products Corporation | Anthranilic acid analogs |
DE10254872A1 (de) | 2002-11-25 | 2004-06-03 | Symrise Gmbh & Co. Kg | Anthranilsäureamide und deren Derivate als kosmetische und pharmazeutische Wirkstoffe |
US8911795B2 (en) * | 2005-11-30 | 2014-12-16 | Symrise Ag | Compositions comprising dihydroavenanthramide D and climbazole as cosmetic and pharmaceutical compositions for alleviating itching |
CA2704380A1 (en) * | 2007-11-08 | 2009-05-14 | Ceapro Inc. | Avenanthramide-containing compositions |
US20170027852A1 (en) * | 2015-07-30 | 2017-02-02 | Truth Aesthetics LLC | Topical Skin Care Composition For Day Use |
WO2017159964A1 (ko) | 2016-03-16 | 2017-09-21 | 전남대학교산학협력단 | 귀리 추출물을 유효성분으로 포함하는 난청의 예방 또는 치료용 약제학적 조성물 |
-
2020
- 2020-03-06 WO PCT/EP2020/056122 patent/WO2021175453A1/en unknown
- 2020-03-06 JP JP2022553577A patent/JP2023516453A/ja active Pending
- 2020-03-06 MX MX2022010964A patent/MX2022010964A/es unknown
- 2020-03-06 EP EP20710136.1A patent/EP4114348A1/en active Pending
- 2020-03-06 US US17/909,342 patent/US20230131993A1/en active Pending
- 2020-03-06 CN CN202080097864.3A patent/CN115209864A/zh active Pending
- 2020-03-06 BR BR112022017573A patent/BR112022017573A2/pt unknown
- 2020-03-06 KR KR1020227034641A patent/KR20220151190A/ko not_active Application Discontinuation
- 2020-03-06 CA CA3172770A patent/CA3172770A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
KR20220151190A (ko) | 2022-11-14 |
CA3172770A1 (en) | 2021-09-10 |
WO2021175453A1 (en) | 2021-09-10 |
US20230131993A1 (en) | 2023-04-27 |
CN115209864A (zh) | 2022-10-18 |
MX2022010964A (es) | 2022-10-18 |
EP4114348A1 (en) | 2023-01-11 |
JP2023516453A (ja) | 2023-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112022017573A2 (pt) | Composição compreendendo uma avenantramida ou um análogo da mesma com estabilidade melhorada | |
BR112013016021A2 (pt) | métodos e composições adequadas para gerenciar glicemia em animais | |
BR112022023462A2 (pt) | 2-amino-3-ciano tiofenos anulados e derivados para o tratamento de câncer | |
Choi et al. | Green tomato extract attenuates high-fat-diet-induced obesity through activation of the AMPK pathway in C57BL/6 mice | |
BR112021018506A2 (pt) | Terapia de combinação para tratamento do câncer | |
BR112018004532A2 (pt) | uso de akkermansia pasteurizado para o tratamento de distúrbios metabólicos | |
BRPI0820068B8 (pt) | uso de cepa de levedura e/ou de uma composição compreendendo cepa de levedura para preparação de um medicamento | |
BR112015010203A8 (pt) | composição para a prevenção ou tratamento de diabetes, complicações diabéticas ou diabesidade, uso de um conjugado análogo da oxintomodulina, e, método para a preparação de um conjugado análogo da oxintomodulina | |
BR112012030177A2 (pt) | composto, uso do mesmo, e, composição farmacêutica | |
BR112022019057A2 (pt) | Aminotiazóis substituídos como inibidores de dgkzeta para ativação imune | |
Lee et al. | Nuclear factor-E2 (Nrf2) is regulated through the differential activation of ERK1/2 and PKC α/βII by Gymnasterkoreayne B | |
BR112018009941A8 (pt) | composição reguladora de crescimento vegetal com efeito sinergético | |
BR112022008497A2 (pt) | Derivados terapêuticos da interleucina-22 | |
Singh et al. | Wound healing activity of standardized extract of Curculigo orchioides in streptozotocin–induced diabetic mice | |
BR112022008000A2 (pt) | Derivado de pirazol-heteroarila, método de preparação para o mesmo e uso médico do mesmo | |
Ahmad et al. | Aqueous extract of dried flower buds of Syzygium aromaticum inhibits inflammation and oxidative stress | |
BR112016025481A2 (pt) | alimentos, sistemas, métodos e estojos para provisão de substituição de eletrólito | |
BR112023024741A2 (pt) | Composto de quinolinamina, método de preparação para o mesmo e aplicação do mesmo em produtos farmacêuticos | |
BR112022017607A2 (pt) | Composição compreendendo uma avenantramida ou um análogo da mesma com melhorada solubilidade | |
BR112022009510A2 (pt) | Análogo de insulina, composição farmacêutica, e, método de tratamento, prevenção ou alívio de uma doença ou distúrbio ou condição | |
BR112022017293A2 (pt) | Composição ou extrato de aveia compreendendo avenantramida e ss-glucano | |
BR112022004674A2 (pt) | Ácido canforsulfônico e combinações do mesmo com excipientes catiônicos como agentes de redução de viscosidade em formulações de proteína altamente concentradas | |
BR112017019753A2 (pt) | uso de composições de astaxantina, composição, processo para preparação de um produto alimentício ou ração, e, preparação medicinal | |
BR112023024125A2 (pt) | Uso de uma composição farmacêutica | |
BR112022019688A2 (pt) | Extrato de fração de folhas de melissa officinalis e nova composição farmacêutica incluindo o mesmo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] |